137 related articles for article (PubMed ID: 38096780)
1. Human antimicrobial peptide inactivation mechanism of enveloped viruses.
Watts S; Hänni E; Smith GN; Mahmoudi N; Freire RVM; Lim S; Salentinig S
J Colloid Interface Sci; 2024 Mar; 657():971-981. PubMed ID: 38096780
[TBL] [Abstract][Full Text] [Related]
2. Ethanol Inactivation of Enveloped Viruses: Structural and Surface Chemistry Insights into Phi6.
Watts S; Ramstedt M; Salentinig S
J Phys Chem Lett; 2021 Oct; 12(39):9557-9563. PubMed ID: 34581569
[TBL] [Abstract][Full Text] [Related]
3. Envelope-deforming antiviral peptide derived from influenza virus M2 protein.
Jung Y; Kong B; Moon S; Yu SH; Chung J; Ban C; Chung WJ; Kim SG; Kweon DH
Biochem Biophys Res Commun; 2019 Sep; 517(3):507-512. PubMed ID: 31375212
[TBL] [Abstract][Full Text] [Related]
4. A mastoparan-derived peptide has broad-spectrum antiviral activity against enveloped viruses.
Sample CJ; Hudak KE; Barefoot BE; Koci MD; Wanyonyi MS; Abraham S; Staats HF; Ramsburg EA
Peptides; 2013 Oct; 48():96-105. PubMed ID: 23891650
[TBL] [Abstract][Full Text] [Related]
5. A review of the antiviral activity of cationic antimicrobial peptides.
Urmi UL; Vijay AK; Kuppusamy R; Islam S; Willcox MDP
Peptides; 2023 Aug; 166():171024. PubMed ID: 37172781
[TBL] [Abstract][Full Text] [Related]
6. Broad-Spectrum Antiviral Entry Inhibition by Interfacially Active Peptides.
Hoffmann AR; Guha S; Wu E; Ghimire J; Wang Y; He J; Garry RF; Wimley WC
J Virol; 2020 Nov; 94(23):. PubMed ID: 32907984
[TBL] [Abstract][Full Text] [Related]
7. 5-(Perylen-3-yl)ethynyl-arabino-uridine (aUY11), an arabino-based rigid amphipathic fusion inhibitor, targets virion envelope lipids to inhibit fusion of influenza virus, hepatitis C virus, and other enveloped viruses.
Colpitts CC; Ustinov AV; Epand RF; Epand RM; Korshun VA; Schang LM
J Virol; 2013 Apr; 87(7):3640-54. PubMed ID: 23283943
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial peptide induced colloidal transformations in bacteria-mimetic vesicles: Combining in silico tools and experimental methods.
Freire RVM; Pillco-Valencia Y; da Hora GCA; Ramstedt M; Sandblad L; Soares TA; Salentinig S
J Colloid Interface Sci; 2021 Aug; 596():352-363. PubMed ID: 33839361
[TBL] [Abstract][Full Text] [Related]
9. Antiviral Activities of Human Host Defense Peptides.
Brice DC; Diamond G
Curr Med Chem; 2020; 27(9):1420-1443. PubMed ID: 31385762
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of the enveloped virus phi6 with hydrodynamic cavitation.
Zupanc M; Zevnik J; Filipić A; Gutierrez-Aguirre I; Ješelnik M; Košir T; Ortar J; Dular M; Petkovšek M
Ultrason Sonochem; 2023 May; 95():106400. PubMed ID: 37060711
[TBL] [Abstract][Full Text] [Related]
11. High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.
Wang G; Mishra B; Epand RF; Epand RM
Biochim Biophys Acta; 2014 Sep; 1838(9):2160-72. PubMed ID: 24463069
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Phi6 Persistence and Suitability as an Enveloped Virus Surrogate.
Aquino de Carvalho N; Stachler EN; Cimabue N; Bibby K
Environ Sci Technol; 2017 Aug; 51(15):8692-8700. PubMed ID: 28657725
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Enveloped Virus Surrogate Phi6 Infection Using Yeast-Derived Vacuoles.
Choi W; Kim YH; Min J
Microbiol Spectr; 2023 Feb; 11(1):e0266122. PubMed ID: 36688634
[TBL] [Abstract][Full Text] [Related]
14. Novel broad spectrum virucidal molecules against enveloped viruses.
Cagno V; Tintori C; Civra A; Cavalli R; Tiberi M; Botta L; Brai A; Poli G; Tapparel C; Lembo D; Botta M
PLoS One; 2018; 13(12):e0208333. PubMed ID: 30532192
[TBL] [Abstract][Full Text] [Related]
15. Biophysical Measurement Strategies for Antiviral Drug Development: Recent Progress in Virus-Mimetic Platforms Down to the Single Particle Level.
Park S; Tae H; Cho NJ
Acc Chem Res; 2021 Aug; 54(16):3204-3214. PubMed ID: 34346210
[TBL] [Abstract][Full Text] [Related]
16. Surfactin Inhibits Membrane Fusion during Invasion of Epithelial Cells by Enveloped Viruses.
Yuan L; Zhang S; Wang Y; Li Y; Wang X; Yang Q
J Virol; 2018 Nov; 92(21):. PubMed ID: 30068648
[TBL] [Abstract][Full Text] [Related]
17. Cathelicidin antimicrobial peptides suppress EV71 infection via regulating antiviral response and inhibiting viral binding.
Yu J; Dai Y; Fu Y; Wang K; Yang Y; Li M; Xu W; Wei L
Antiviral Res; 2021 Mar; 187():105021. PubMed ID: 33508330
[TBL] [Abstract][Full Text] [Related]
18. The Broad-Spectrum Antiviral Potential of the Amphibian Peptide AR-23.
Chianese A; Zannella C; Monti A; De Filippis A; Doti N; Franci G; Galdiero M
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055066
[TBL] [Abstract][Full Text] [Related]
19. Surfactants - Compounds for inactivation of SARS-CoV-2 and other enveloped viruses.
Simon M; Veit M; Osterrieder K; Gradzielski M
Curr Opin Colloid Interface Sci; 2021 Oct; 55():101479. PubMed ID: 34149296
[TBL] [Abstract][Full Text] [Related]
20. Antiviral peptide engineering for targeting membrane-enveloped viruses: Recent progress and future directions.
Jackman JA
Biochim Biophys Acta Biomembr; 2022 Feb; 1864(2):183821. PubMed ID: 34808121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
